Press release – Transgene

Transgene and BioInvent present preclinical data demonstrating BT-001’s powerful activity against solid tumors

20200515 BT-001_AACR curtain raiser EN

By nh|2020-05-14T17:41:23+02:00May 15th, 2020|BT-001, Invir.IO, Press release|Comments Off

20200515_AACR myvac curtain raiser EN

By nh|2020-05-14T17:13:26+02:00May 15th, 2020|Myvac, Press release, TG4050|Comments Off

20200506 TG FINANCIAL T1- US

By nh|2020-05-06T16:30:35+02:00May 6th, 2020|Press release|Comments Off

20200504 - TG Vaxxell EN

By Lucie Larguier|2020-04-30T16:44:28+02:00May 4th, 2020|Press release|Comments Off

20200402PR-EN availability URD 2019

By Lucie Larguier|2020-04-03T17:12:49+02:00April 3rd, 2020|Press release|Comments Off

20200403 - availability doc AG - EN

By Lucie Larguier|2020-04-03T17:40:37+02:00April 3rd, 2020|Press release|Comments Off

20200311 Resultats 2019 EN

By nh|2020-03-11T16:43:17+01:00March 11th, 2020|Press release|Comments Off

20200303 BT-001 presentations EN

By nh|2020-03-02T18:01:26+01:00March 3rd, 2020|BT-001, Press release|Comments Off

20200220 PR FPI 6002.03 EN

By nh|2020-02-20T16:40:21+01:00February 20th, 2020|Press release, TG6002, TG6002|Comments Off

20200107 PR TG4050 FPI - EN

By nh|2020-03-04T16:12:15+01:00January 7th, 2020|Press release, TG4050|Comments Off